Ted Jenkins
Vice President, Head of Investor Relations
Head of Investor Relations
Earnings-call appearances
-
Spero Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-10
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-11
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q4 FY2022 Earnings Call2023-03-30
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-14
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-10
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-16
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-31
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-10
Spero Therapeutics, Inc. (SPRO)
-
Spero Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-05
Spero Therapeutics, Inc. (SPRO)